Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

• Olaf Schultz,

  Affiliation Department of Internal Medicine II and Centre of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Frank Oberhauser,

  Affiliation Department of Internal Medicine II and Centre of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Jasemine Saech,

  Affiliation Department of Internal Medicine I, University of Cologne, Cologne, Germany

  ⨯
• Andrea Rubbert-Roth,

  Affiliation Department of Internal Medicine I, University of Cologne, Cologne, Germany

  ⨯
• Moritz Hahn,

  Affiliation Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany

  ⨯
• Wilhelm Krone,

  Affiliations Department of Internal Medicine II and Centre of Molecular Medicine Cologne, University of Cologne, Cologne, Germany, CECAD-Cluster of Excellence in Cellular Stress Responses in Aging Associated Diseases, University of Cologne, Cologne, Germany

  ⨯
• Matthias Laudes

  * E-mail: matthias.laudes@uk-koeln.de

  Affiliation Department of Internal Medicine II and Centre of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯